Literature DB >> 17457050

The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation.

Toshiaki Inoue1, Masaharu Hiratsuka, Mitsuhiko Osaki, Mitsuo Oshimura.   

Abstract

Sir2, an NAD+-dependent protein deacetylase, extends the lifespan in diverse species from yeast to flies. Mammals have seven homologs of Sir2, SIRT1-7, which affect aging and metabolism and which are potential targets for pharmacologic intervention. We identified SIRT2, which preferentially deacetylates tubulin and histone H4, as a downregulated protein in gliomas due to its epigenetic aberration. We herein discuss the role of SIRT2 in the mitotic checkpoint function and show that it may be as a potential target of anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457050     DOI: 10.4161/cc.6.9.4219

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  72 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

2.  The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes.

Authors:  Ben Buelow; Yumei Song; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 3.  Calorie restriction and the exercise of chromatin.

Authors:  Alejandro Vaquero; Danny Reinberg
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

Review 4.  How histone deacetylases control myelination.

Authors:  Claire Jacob; Frédéric Lebrun-Julien; Ueli Suter
Journal:  Mol Neurobiol       Date:  2011-08-23       Impact factor: 5.590

Review 5.  Sirtuins and the Metabolic Hurdles in Cancer.

Authors:  Natalie J German; Marcia C Haigis
Journal:  Curr Biol       Date:  2015-06-29       Impact factor: 10.834

6.  Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.

Authors:  Michaël Van Damme; Emerence Crompot; Nathalie Meuleman; Philippe Mineur; Barbara Dessars; Hakim El Housni; Dominique Bron; Laurence Lagneaux; Basile Stamatopoulos
Journal:  Epigenetics       Date:  2014-10       Impact factor: 4.528

7.  RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation.

Authors:  Merlin P Thangaraj; Kendra L Furber; Jotham K Gan; Shaoping Ji; Larhonda Sobchishin; J Ronald Doucette; Adil J Nazarali
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

8.  Sirtuin deacetylases: a new target for melanoma management.

Authors:  Melissa J Wilking; Chandra K Singh; Minakshi Nihal; Mary A Ndiaye; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

10.  Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii.

Authors:  Huawen Lin; Alan L Kwan; Susan K Dutcher
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.